期刊文献+

不完全性川崎病急性期细胞免疫和体液免疫功能分析 被引量:4

Cellular and humoral immunity condition with incomplete Kawasaki disease in the acute period
在线阅读 下载PDF
导出
摘要 目的探讨不完全性川崎病(iKD)患儿急性期细胞免疫和体液免疫功能的变化,及对临床诊治的意义。方法将70例川崎病患儿分为iKD组(35例),完全性川崎病(cKD)组35例,21例腹股沟疝患儿为对照组。分别测定其外周血淋巴细胞亚群(CD3+、CD3+CD4+、CD3+CD8+、CD4+/CD8+、CD19+、自然杀伤细胞)与血清免疫球蛋白(IgG、IgA、IgM)水平变化,比较3组间的差异。结果与对照组比较,iKD组与cKD组CD4+、CD4+/CD8+、CD19+、IgG、IgA、IgM水平升高(P<0.05),CD8+细胞、自然杀伤细胞水平下降(P<0.05);iKD组与cKD组CD4+/CD8+、CD3+水平比较差异有统计学意义(P<0.05)。结论 iKD患儿急性期同样存在免疫系统高度活化,但其细胞免疫活化程度不如cKD者显著。 Objective To analyze the cellular and humoral immunity condition in children with incomplete Kawasaki disease (iKD). Methods Seventy children with KD were divided into three groups, i. e. iKD group (n = 35) cKD group ( n = 35 ) , inguinal hernia control group (n = 21 ). The level variation of lymphocyte subsets (CD3 +, CD3 + CD4+, CD3 + CD8 +, CD4+/CD8 +, CD19+ NK cell) and humoral immunity ( IgG, IgA, IgM) were compared among three groups. Results Compared with the control group, the level of CD4+, CD4+/CD8+, CD19+, IgG, IgA, IgM increase (P 〈0. 05) in the children with iKD or cKD, the level of CD8 ~ , NK cell decreased ( P 〈 0. 05 ) at the same time. There was statistical difference of CD4 +/CD8 ~ in iKD and cKD ( P 〈 0. 05 ). Conclusions Children in the acute period of iKD have active function in cellular and humoral immunity, the level of active function in cellular immunity is not significant as the ones of cKD.
出处 《新医学》 2013年第9期636-638,共3页 Journal of New Medicine
关键词 川崎病 淋巴细胞亚群 免疫球蛋白 儿童 不完全性 Kawasaki disease Lymphocyte subsets Immune globulin Child Incomplete
  • 相关文献

参考文献7

二级参考文献44

  • 1史乾,范慧敏,刘中民.Treg/Th17平衡的分子调节机制[J].现代免疫学,2008,28(6):510-513. 被引量:10
  • 2朱卫东,刘特长.川崎病患儿血小板参数和免疫球蛋白测定结果分析[J].中国现代医学杂志,2005,15(9):1401-1403. 被引量:10
  • 3Mitani Y, Sawada H, Hayakawa H et al. Elevated levels of high - sensitivity C - reactive protein and serum amyloid - A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease [J] . Circulation, 2005, 111 (1) : 38.
  • 4Lee TJ, Chun JK, Yeon SI et al. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease [J]. Scand J Rheumatol, 2007, 36 (3): 222.
  • 5Suzuki H, Muragaki Y, Uemura Set al. Detection of auto - antibodies against a 70 KDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease[J].Eur J Pediatr, 2002, 161 (6) : 324.
  • 6Matsubara K, Fukaya T, Miwa K et al. Development of serum IgM antibodies against superantigens of staphylococcus aureus and streptococcus pyogenes in Kawasaki disease [J]. Clin Exp Immunol, 2006, 143 (3): 427.
  • 7Sakata K, Hamaoka K, Ozawa Set al. A randomized prospective study on the use of 2 g - IVIG or 1 g - IVIG as therapy for Kawasaki disease [J] . EurJ Pediatr, 2007, 166 (6): 565.
  • 8Leung DY, Meissner HC, Shulman ST et al. Prevalence of superantigen -secreting bacteria in patients with Kawasaki disease [J].J Pediatr, 2002, 140 (6): 742.
  • 9Duong TT, Silverman ED, Bissessar MV et al. Saperantigenic activity is responsible for induction of coronary arteritis in mice an animal model of Kawasaki disease[J].nt Immunol, 2003, 15 (1) : 79.
  • 10Tsujimoto H, Takeshita S, Nakatani K et al. Delayed apoptosis of circutating neutrophils in Kawasaki disease [J]. Clin Exp Immunol, 2001, 126 (2): 355.

共引文献15

同被引文献46

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部